Biogen Inc. (BIIB) stock prices updated...
 

Biogen Inc. stock price, BIIB

Biogen Inc. stock chart:



Biogen Inc. close price: 274.82

Stock price forecast:

UP TO +3.96%
Target: 285.71

Total forecasts: 89
Reached: 63 (70.79%)

Total Win: 411.04 (147.54%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90916369.23%411.041.62%7,985.57-290.61-3.64%120.430.47%
30312270.97%99.031.10%2,485.92-12.54-0.50%86.490.97%
1415640.00%20.050.46%2,485.92-12.54-0.50%7.510.18%
7800.00%0.000.00%2,206.96-8.40-0.38%-8.40-0.38%

Showing 1-10 of 427 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-03-25274.82285.710000-00-00
2017-03-24275.41285.930000-00-00
2017-03-23277.87284.480000-00-00
2017-03-22275.79280.810000-00-00
2017-03-21274.8280.510000-00-00
2017-03-20276.09282.830000-00-00
2017-03-19276.09278.210000-00-00
2017-03-18276.09278.210000-00-00
2017-03-17278.96279.070000-00-00
2017-03-16292.64289.062017-03-16

Biogen Inc. latest news:


  • 03/21/2017 10:26:38

    Biogen wins ruling in Tecfidera IP case; shares rise

    Biogen Inc(BIIB) on Tuesday won an intellectual property rights ruling against hedge fund manager Kyle Bass over its top multiple sclerosis pill, Tecfidera, pushing shares up more than 1 percent on a day when most U.S. stocks were down. The ruling came from the U.S. Patent and Trademark Office's Patent Trial and Appeal Board in Washington.

  • More trends:

    Biolase, Inc.BIOL | BioLife Solutions, Inc.BLFS | BioLineRx Ltd.BLRX | BioMarin Pharmaceutical Inc.BMRN | BiondVax Pharmaceuticals Ltd.BVXV | BiondVax Pharmaceuticals Ltd.BVXVW | Bio-Path Holdings, Inc.BPTH | BioScrip, Inc.BIOS | BioShares Biotechnology Clinical Trials FundBBC | BioShares Biotechnology Products FundBBP |